KV

Kataru Venkata Krishna Prasad

Active Director Director DIN 08659992
DIN 08659992 First appointment Nov 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kataru Venkata Krishna Prasad

Data last updated:

Kataru Venkata Krishna Prasad is a Director at Hepius Medicare Private Limited (since 2023). The company operates in Chemicals.

DIN 08659992
Primary Designation Director
Industry Chemicals
First Appointment 11 Nov 2023
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hepius Medicare Private Limited U24290TG2020PTC138227
Director11 Nov 20232020Active

Board colleagues of Kataru Venkata Krishna Prasad

NameDINCompanyDesignation
Pavan Kumar Kidambi08658860Hepius Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hepius Medicare Private Limited
Premium access

Shareholding and investment profile for Kataru Venkata Krishna Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kataru Venkata Krishna Prasad

Kataru Venkata Krishna Prasad currently holds 1 directorship: Hepius Medicare Private Limited (Director, since 11 Nov 2023).

Kataru Venkata Krishna Prasad was first appointed on 11 Nov 2023 as Director at Hepius Medicare Private Limited.

The current boards of Kataru Venkata Krishna Prasad's companies include Pavan Kumar Kidambi (Hepius Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available